All-trans retinoic acid and early mortality in acute promyelocytic leukemia-Reference-Cited by-同舟云学术

All-trans retinoic acid and early mortality in acute promyelocytic leukemia

Published:2013-10 Issue:10 Volume:37 Page:1391-1392
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Rashidi Armin,Goudar Ranjit K.,Sayedian Farzaneh,Vos Jeffrey A.,Goldin Teresa A.,Aguilera Nadine S.,Fisher Stephen I.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference2 articles.

1. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death;Altman;Leuk Res,2013

2. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups;Sanz;Blood,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort;European Journal of Haematology;2023-12-14

2. A risk score based on real-world data to predict early death in acute promyelocytic leukemia;Haematologica;2022-01-27

3. Timely APL diagnosis and treatment should be available to all;Haematologica;2021-07-29

4. miR-139-5p Regulates the Proliferation of Acute Promyelocytic Leukemia Cells by Targeting MNT;Journal of Oncology;2021-04-16

5. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone;Blood Cells, Molecules, and Diseases;2019-11